Viewing Study NCT00088166


Ignite Creation Date: 2025-12-24 @ 4:16 PM
Ignite Modification Date: 2026-02-20 @ 5:49 AM
Study NCT ID: NCT00088166
Status: COMPLETED
Last Update Posted: 2014-08-13
First Post: 2004-07-20
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: XERECEPT® (hCRF) for Patients Requiring Dexamethasone to Treat Edema Associated With Brain Tumors
Sponsor: Celtic Pharma Development Services
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: NTI 0303
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View